Chronic treatment with the mood-stabilizing drug lithium up-regulates nuclear factor E2-related factor 2 in rat pheochromocytoma PC12 cells in vitro

Neuroscience

Volumn 256, Issue , 2014, Pages 223-229

  Rizak, J ^a,c   Tan, H ^b   Zhu, H ^a,d   Wang, J F ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c KUNMING INSTITUTE OF ZOOLOGY   (China)

^d GUANGZHOU INSTITUTE OF DERMATOLOGY   (China)

Author keywords

Bipolar disorder; Electrophile response element; Lithium; Nuclear factor E2 related factor 2; Oxidative stress

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE A4; HYDROGEN PEROXIDE; LITHIUM; MOOD STABILIZER; NUCLEAR PROTEIN; OLIGONUCLEOTIDE; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NF E2; LITHIUM CHLORIDE; OXIDIZING AGENT; SMALL INTERFERING RNA; TRANQUILIZER; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL PROTECTION; CELL VIABILITY; DNA FRAGMENTATION; DRUG MECHANISM; ELECTROPHILIC STRESS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; IN VITRO STUDY; LONG TERM CARE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RAT; UPREGULATION; ANIMAL; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; METABOLISM; NICK END LABELING; PC12 CELL LINE; TIME;

ANIMALS; ANTIMANIC AGENTS; CELL SURVIVAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HYDROGEN PEROXIDE; IN SITU NICK-END LABELING; LITHIUM CHLORIDE; NF-E2-RELATED FACTOR 2; OXIDANTS; PC12 CELLS; RATS; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 84888103634     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.10.036     Document Type: Article

References (45)

1. Andreazza A.C., Shao L., Wang J.F., Young L.T. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 2010, 67:360-368.
2. Andreazza A.C., Wang J.F., Salmasi F., Shao L., Young L.T. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem 2013, [Epub ahead of print].
3. Bachmann R.F., Schloesser R.J., Gould T.D., Manji H.K. Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Mol Neurobiol 2005, 32:173-202.
4. Bloom D.A., Jaiswal A.K. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J Biol Chem 2003, 278:44675-44682.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-252.
6. Bryan H.K., Olayanju A., Goldring C.E., Park B.K. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem Pharmacol 2012, 85:705-717.
7. Chan J.Y., Kwong M. Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys Acta 2000, 1517:19-26.
8. Chanas S.A., Jiang Q., McMahon M., McWalter G.K., McLellan L.I., Elcombe C.R., Henderson C.J., Wolf C.R., Moffat G.J., Itoh K., Yamamoto M., Hayes J.D. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem J 2002, 365:405-416.
9. Che Y., Wang J.F., Shao L., Young L.T. Oxidative damage to RNA but not DNA occurs in hippocampus of subjects with major mental illness. J Psychiatry Neurosci 2010, 35:296-302.
10. Chen G., Zeng W.Z., Yuan P.X., Huang L.D., Jiang Y.M., Zhao Z.H., Manji H.K. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 1999, 72:879-882.
11. Chen R.W., Qin Z.H., Ren M., Kanai H., Chalecka-Franaszek E., Leeds P., Chuang D.M. Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection. J Neurochem 2003, 84:566-575.
12. Chuang D.M. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann N Y Acad Sci 2005, 1053:195-204.
13. Clay H.B., Sillivan S., Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 2011, 29:311-324.
14. Correa C., Amboni G., Assis L.C., Martins M.R., et al. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Prog Neuro-Psychopharmacol Biol Psychiatry 2007, 31:887-891.
15. Cui J., Shao L., Young L.T., Wang J.F. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 2007, 144:1447-1453.
16. Forman H.J., Dickinson D.A. Oxidative signaling and glutathione synthesis. Biofactors 2003, 17:1-12.
17. Frey B.N., Valvassori S.S., Reus G.Z., Martins M.R., et al. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 2006, 31:326-332.
18. Grimes C.A., Jope R.S. CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem 2001, 78:1219-1232.
19. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005, 45:51-88.
20. Jain A.K., Jaiswal A.K. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J Biol Chem 2006, 281:12132-12142.
21. Jain A.K., Jaiswal A.K. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 2007, 282:16502-16510.
22. Kato T. The role of mitochondrial dysfunction in bipolar disorder. Drug News Perspect 2006, 19:597-602.
23. Keum Y.S., Yu S., Chang P.P., Yuan X., Kim J.H., Xu C., et al. Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells. Cancer Res 2006, 66:8804-8813.
24. King T.D., Jope R.S. Inhibition of glycogen synthase kinase-3 protects cells from intrinsic but not extrinsic oxidative stress. Neuroreport 2005, 16:597-601.
25. Lai J.S., Zhao C., Warsh J.J., Li P.P. Cytoprotection by lithium and valproate varies between cell types and cellular stresses. Eur J Pharmacol 2006, 539:18-26.
26. Lindsay J., Esposti M.D., Gilmore A.P. Bcl-2 proteins and mitochondria-specificity in membrane targeting for death. Biochim Biophys Acta 2011, 1813:532-539.
27. Niture S.K., Jaiswal A.K. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J Biol Chem 2012, 287:9873-9886.
28. Numazawa S., Ishikawa M., Yoshida A., Tanaka S., Yoshida T. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am J Physiol Cell Physiol 2003, 285:C334-C342.
29. Reisman S.A., Yeager R.L., Yamamoto M., Klaassen C.D. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species. Toxicol Sci 2009, 108:35-47.
30. Rojo A.I., Sagarra M.R., Cuadrado A. GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem 2008, 105:192-202.
31. Schafer M., Goodenough S., Moosmann B., Behl C. Inhibition of glycogen synthase kinase 3 beta is involved in the resistance to oxidative stress in neuronal HT22 cells. Brain Res 2004, 1005:84-89.
32. Shao L., Young L.T., Wang J.F. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry 2005, 58:879-884.
33. Shao L., Cui J., Young L.T., Wang J.F. The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes. Neuroscience 2008, 151:518-524.
34. Sharma R., Yang Y., Sharma A., Awasthi S., Awasthi Y.C. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal 2004, 6:289-300.
35. Stambolic V., Ruel L., Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 1996, 6:1664-1668. Erratum in: Curr Biol. 1997 7:196.
36. Tan H., Shao L., Che Y., Young L.T., Honer W.G., Wang J.F. Mood stabilizer lithium prevents amphetamine-increased adductions of 4-hydroxynonenal with presynaptic proteins in rat frontal cortex. Int J Neuropsychopharmacol 2012, 15:1275-1285.
37. Tang V., Wang J.F. Oxidative stress in bipolar disorder. Biochem Anal Biochem 2012, S2-002.
38. Valvassori S.S., Rezin G.T., Ferreira C.L., Moretti M., et al. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. J Psychiatric Res 2010, 44:903-909.
39. Vargas M.R., Johnson J.A. The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev Mol Med 2009, 11:e17.
40. Wang J.F. Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment. Can J Psychiatry 2007, 52:753-762.
41. Wang J.F., Shao L., Sun X., Young L.T. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord 2009, 11:523-529.
42. Wild A.C., Moinova H.R., Mulcahy R.T. Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 1999, 274:33627-33636.
43. Yan X.B., Hou H.L., Wu L.M., Liu J., Zhou J.N. Lithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia. Neuropharmacology 2007, 53:487-495.
44. Yuan X., Xu C., Pan Z., Keum Y.S., Kim J.H., Shen G., et al. Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells. Mol Carcinog 2006, 45:841-850.
45. Zhang R., Chae S., Lee J.H., Hyun J.W. The cytoprotective effect of butin against oxidative stress is mediated by the up-regulation of manganese superoxide dismutase expression through a PI3K/Akt/Nrf2-dependent pathway. J Cell Biochem 2012, 113:1987-1997.